Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human DNase I hyperactive variants

Human DNase I hyperactive variants

US Patent 7407785 · Granted Aug 5, 2008

Estimated economic value: $111,803,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fc containing polypeptides with altered glycosylation and reduced effector funct2025
scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidi2025
Parathyroid hormone variants2025
Oligosaccharide-protein conjugates2025
Site-specific antibody-drug conjugation through glycoengineering2024
scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidi2024
Hyperglycosylated binding polypeptides2023
Site-specific glycoengineering of targeting moieties2023
Affinity purification of glycosidase-cleaving enzymes2023
GLP-2 analogs and peptibodies for administration before, during or after surgery2023
Parathyroid hormone variants2023
scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidi2022